188 related articles for article (PubMed ID: 36766695)
21. Selective monitoring of the enzymatic activity of the tumor suppressor Fhit.
Hacker SM; Mortensen F; Scheffner M; Marx A
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10247-50. PubMed ID: 25098403
[TBL] [Abstract][Full Text] [Related]
22. The tumor suppressor protein Fhit. A novel interaction with tubulin.
Chaudhuri AR; Khan IA; Prasad V; Robinson AK; Ludueña RF; Barnes LD
J Biol Chem; 1999 Aug; 274(34):24378-82. PubMed ID: 10446217
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and immunochemical characterisation of human diadenosine triphosphatase provides evidence for its identification with the tumour suppressor Fhit protein.
Asensio AC; Rodríguez-Ferrer CR; Oaknin S; Rotllán P
Biochimie; 2006 May; 88(5):461-71. PubMed ID: 16359767
[TBL] [Abstract][Full Text] [Related]
24. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells.
Lee TG; Jeong EH; Kim SY; Kim HR; Kim H; Kim CH
Oncotarget; 2017 May; 8(19):31923-31937. PubMed ID: 28404875
[TBL] [Abstract][Full Text] [Related]
25. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.
Yutori H; Semba S; Komori T; Yokozaki H
Cancer Sci; 2008 Mar; 99(3):524-30. PubMed ID: 18167129
[TBL] [Abstract][Full Text] [Related]
26. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
27. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
[TBL] [Abstract][Full Text] [Related]
28. MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family.
Lima CD; D'Amico KL; Naday I; Rosenbaum G; Westbrook EM; Hendrickson WA
Structure; 1997 Jun; 5(6):763-74. PubMed ID: 9261067
[TBL] [Abstract][Full Text] [Related]
29. In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals.
Kowara R; Karaczyn AA; Fivash MJ; Kasprzak KS
Chem Res Toxicol; 2002 Mar; 15(3):319-25. PubMed ID: 11896678
[TBL] [Abstract][Full Text] [Related]
30. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
Barnes LD; Garrison PN; Siprashvili Z; Guranowski A; Robinson AK; Ingram SW; Croce CM; Ohta M; Huebner K
Biochemistry; 1996 Sep; 35(36):11529-35. PubMed ID: 8794732
[TBL] [Abstract][Full Text] [Related]
31. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
Pecherzewska R; Nawrot B
Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
[TBL] [Abstract][Full Text] [Related]
32. Expression in Escherichia coli and simple purification of human Fhit protein.
Pawelczyk T; Kowara R; Golebiowski F; Matecki A
Protein Expr Purif; 2000 Apr; 18(3):320-6. PubMed ID: 10733886
[TBL] [Abstract][Full Text] [Related]
33. Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy.
Askari MD; Vo-Dinh T
Biopolymers; 2004 Mar; 73(4):510-23. PubMed ID: 14991669
[TBL] [Abstract][Full Text] [Related]
34. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.
Jayachandran G; Sazaki J; Nishizaki M; Xu K; Girard L; Minna JD; Roth JA; Ji L
Cancer Res; 2007 Nov; 67(21):10379-88. PubMed ID: 17974981
[TBL] [Abstract][Full Text] [Related]
35. [Interaction between abnormal expression of fragile histidine triad and methyl-CpG-binding protein 2 on cervical cancerization].
Yang Q; Li Y; Wang L; Song ZC; Feng MJ; Ding L; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):689-693. PubMed ID: 29860820
[No Abstract] [Full Text] [Related]
36. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
37. Fragile histidine triad gene and skin cancer.
Zanesi N; Croce CM
Eur J Dermatol; 2001; 11(5):401-4. PubMed ID: 11525944
[TBL] [Abstract][Full Text] [Related]
38. Tumor suppressor Fhit protein interacts with protoporphyrin IX in vitro and enhances the response of HeLa cells to photodynamic therapy.
Zawacka-Pankau J; Kowalska A; Issaeva N; Burcza A; Kwiek P; Bednarz N; Pramanik A; Banecki B; Podhajska AJ
J Photochem Photobiol B; 2007 Jan; 86(1):35-42. PubMed ID: 16990010
[TBL] [Abstract][Full Text] [Related]
39. Association of activated Gαq to the tumor suppressor Fhit is enhanced by phospholipase Cβ.
Zuo H; Wong YH
BMC Cancer; 2015 Oct; 15():775. PubMed ID: 26497576
[TBL] [Abstract][Full Text] [Related]
40. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]